BOSTON — May 8, 2017 — On May 12, David J. Dykeman, patent attorney, co-chair of Greenberg Traurig, LLP’s global Life Sciences & Medical Technology Group and the Boston Intellectual Property (IP) Group, will moderate the Massachusetts Biotechnology Council (MassBio) symposium, “The Convergence of Medical Device & Drugs: The Future of Combination Products.”
From 1:30 - 2:45 p.m., this panel discussion will cover innovation and development in combination products, including scientific advances, medical challenges being addressed by combination products, strategies for funding new combination product ventures, development issues specific to combination products, and the regulatory environment.
Panelists include:
- Steve Bowman, Device Project Lead, Shire
- Laura Indolfi, CEO, PanTher Therapeutics, TED Fellow, Entrepreneur in Residence, MGH Cancer Center
- Peter Markham, President & CEO, CBSET
- Ailis Tweed-Kent, CEO, Co-founder, Cocoon Biotech Inc.
With over 20 years of experience in patents, IP, and licensing, Dykeman focuses his practice on securing strategic worldwide IP protection and related business strategy for high-tech clients, with particular experience in medical devices, life sciences, biotechnology, and healthcare IT. Dykeman is the founding co-chair of the American Bar Association’s (ABA) Medical Devices Committee and served on the Editorial Advisory Board of Medical Device + Diagnostic Industry (MD+DI) magazine. An accomplished author and a speaker on medical devices and life sciences IP, Dykeman was honored as a “Life Science Star” by LMG Life Sciences, and was named one of the Top 250 Patent and Technology Licensing Practitioners in the world by Intellectual Asset Management (IAM) magazine.
About Greenberg Traurig’s Life Sciences & Medical Technology Group
Greenberg Traurig’s Life Sciences & Medical Technology Group advises clients ranging from startups to large multinational public companies to leading research institutions. The group’s attorneys work closely with clients, providing innovative legal counsel to help them achieve their objectives – from discovery through commercialization and product marketing.
About Greenberg Traurig, LLP
Greenberg Traurig, LLP (GTLaw) has more than 2,000 attorneys in 38 offices in the United States, Latin America, Europe, Asia and the Middle East and is celebrating its 50th anniversary. One firm worldwide, GTLaw has been recognized for its philanthropic giving, was named the second largest firm in the U.S. by Law360 in 2016, and among the Top 20 on the 2016 Am Law Global 100. Web: www.gtlaw.com Twitter: @GT_Law.